Page 19 of 20
AS4.1-7 | General Anaesthesia — Assignment
CLINICAL SCENARIO
You will produce a comprehensive pre-operative anaesthetic assessment and plan for a standardised clinical vignette — a real clinical deliverable that junior anaesthetists produce before every general anaesthetic. This document integrates patient risk stratification (ASA grading), airway assessment (Mallampati + other predictors), choice and dosing of anaesthetic agents, intraoperative monitoring plan, vital-organ support strategy, and post-operative recovery pathway. The skill of translating a patient's history, examination, and investigations into a safe, evidence-based anaesthetic plan is the core clinical competency of the anaesthesiologist.
Instructions
- Read the patient vignette below carefully.
Vignette: Mr Ramesh, a 62-year-old male (weight 78 kg, height 168 cm, BMI 27.6), is listed for elective laparoscopic right hemicolectomy for a T2N0 carcinoma of the ascending colon under general anaesthesia. Past medical history: hypertension (well controlled on amlodipine 5 mg OD), type 2 diabetes (metformin 500 mg BD; HbA1c 7.2%), mild COPD (FEV1/FVC 0.68; on salbutamol PRN). No known drug allergies. Mouth opening 4 cm; neck extension full; thyromental distance 6.5 cm; on pharyngeal examination with mouth wide open and tongue protruded, soft palate, uvula, and fauces are visible but tonsillar pillars are partially obscured. He had a uneventful appendicectomy 20 years ago under general anaesthesia. He last ate a full meal 8 hours ago and drank clear fluids 3 hours ago.
- Assign an ASA physical status classification (I–VI) with justification.
3. Perform a structured airway assessment:
a. Assign the Mallampati class with justification (remember: Mallampati grades the oropharyngeal view, NOT systemic disease — do not confuse with ASA).
b. List three other bedside predictors of difficult intubation that should be assessed and their expected values in this patient.
c. Predict the likely Cormack-Lehane grade and explain your reasoning.
4. Design an anaesthetic plan covering:
a. Pre-medication and fasting confirmation (apply the 2-4-6-8 rule explicitly).
b. Induction: name the agent and dose in mg/kg (for Ramesh's weight), type of intubation, muscle relaxant and dose.
c. Maintenance: agent(s) and delivery method; monitoring (list minimum 5 monitors with their clinical purpose).
d. Vital organ support: circulatory, respiratory, temperature, and fluid management strategy.
e. Emergence and extubation criteria.
- Identify two potential intraoperative complications specific to laparoscopic abdominal surgery and describe how you would recognise and manage each.
- Outline the post-operative recovery plan including pain management strategy (multimodal, opioid-sparing where possible) and criteria for safe discharge from the recovery room.
Word guidance: 700–950 words (excluding tables/diagrams if used).
Length: 700-950 words
Grading Rubric — General Anaesthesia Assignment Rubric
| Criterion | Points | Full-marks descriptor |
|---|---|---|
| ASA Classification and Airway Assessment: Correct ASA grade with justification; correct Mallampati class with description of pharyngeal findings; three valid bedside airway predictors identified; reasoning for C-L grade prediction is anatomically sound | 20 pts | ASA III correctly assigned with justification for all three comorbidities; Mallampati II correctly identified with accurate description of what is seen; three valid predictors (e.g., ULBT, thyromental distance, mouth opening) cited with expected values; C-L grade prediction logically derives from the airway assessment |
| Anaesthetic Plan — Agents and Doses: Induction agent named with correct mg/kg dose and actual dose for 78 kg; fasting confirmation applies 2-4-6-8 rule; muscle relaxant choice and dose correct; maintenance strategy appropriate for laparoscopic surgery | 25 pts | Propofol 1.5–2.5 mg/kg cited with actual dose range (117–195 mg) correctly calculated; 2-4-6-8 rule explicitly applied and patient confirmed to meet clear-fluid criterion (3 h) and solid-food criterion (8 h); non-depolarising NMBA at correct dose; maintenance with volatile or TIVA with rationale; all doses in mg/kg |
| Monitoring and Vital Organ Support: Minimum five monitors named with specific clinical purpose for each; organ-support strategy covers circulation, ventilation, temperature, and fluids; monitoring plan is appropriate for laparoscopic surgery | 20 pts | Five monitors named with a clinically meaningful purpose for each (e.g., capnography = confirms ETT position, detects CO₂ absorption from insufflation, estimates PaCO₂); circulatory support addresses PONV, laparoscopic haemodynamic shifts, Trendelenburg; temperature monitoring + active warming mentioned; fluid management includes goal-directed or maintenance strategy |
| Laparoscopic Complications and Recovery Plan: Two laparoscopic-specific complications correctly identified; recognition and management described accurately; recovery criteria and multimodal analgesia plan are clinically sound | 20 pts | Two valid laparoscopic complications described (e.g., CO₂ absorption → rising ETCO₂ + hypercapnia; gas embolism; surgical emphysema; haemodynamic shifts from Trendelenburg/pneumoperitoneum); recognition criteria specific; management steps correct; recovery criteria include standard parameters (consciousness, SpO₂, pain, PONV); analgesia is multimodal and opioid-sparing |
| Clinical Reasoning and Integration: The plan is coherent, internally consistent, and patient-specific (calculations use 78 kg); ASA and Mallampati are not confused; evidence-based reasoning is applied throughout; writing is concise and within word guidance | 15 pts | All calculations use patient weight; no conflation of ASA with Mallampati; plan is logically sequenced from pre-op through recovery; evidence-based reasoning cited for key choices; within 700–950 words |
PEER REVIEW
Review your peer's anaesthetic plan using the following checklist:
1. ASA Grade: Is the grade correct and is the justification specific to the patient's three comorbidities? (ASA III for two controlled comorbidities + mild COPD)
2. Mallampati: Is it correctly assigned as Class II (soft palate, uvula, fauces visible; tonsillar pillars partially obscured)? Is it clearly distinguished from ASA?
3. Drug doses: Are all doses given in mg/kg? Has the author calculated the actual dose for a 78 kg patient? Flag any doses outside the safe range.
4. Fasting: Is the 2-4-6-8 rule explicitly applied? Has the author correctly confirmed the patient meets both criteria (clear fluids ≥2 h, last solid meal ≥6 h)?
5. Monitoring: Are at least five monitors listed with a meaningful clinical purpose for each?
6. Laparoscopic complications: Are both complications specific to laparoscopic surgery (not generic)? Is management evidence-based?
7. Highlight one strength and one area for improvement.